home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Accelerating Drug Discovery from Virtual Screening to Lead Optimization

 
  October 17, 2025  
     
 
Xtalks, Online
2025-11-06


Drug discovery teams face growing pressure to shorten timelines, improve hit-to-lead progression and manage the rising complexity of data across computational and experimental workflows. Join this webinar to see how AI-driven computational tools and collaborative data environments can overcome these challenges by streamlining virtual screening, molecular design and data management.

The featured speakers will examine an AI-powered quantum chemistry platform for photocatalyst discovery using generative biology and machine learning approaches.

Attendees will explore methods for validating computationally discovered candidates and translating them into functional assays.

The session will also show how a digital design environment enables teams to digitally design molecules, access and analyze experimental and virtual data and collaborate within a single workspace.

The speakers will also explain how a collaborative database supports protocol setup and assay data organization, linking experimental systems with data management workflows. Case studies will illustrate successful implementations with measurable improvements in discovery timelines and hit-to-lead progression.

Register for this webinar to learn how integrated computational and data management approaches can accelerate drug discovery from virtual screening to lead optimization.

Keywords: AI, Bioinformatics, Computational Modeling and Simulation, Drug Candidate, Drug Discovery, Drug Screening, Hit to Lead, In Silico, Lead Optimization, Medicinal Chemistry, Other Software
 
 
Organized by: Xtalks
Invited Speakers: Ajay Yekkirala, PhD, Co-Founder and SVP, Head of Discovery and Development, Superluminal Medicines Inc.
Mark Fitzgerald, PhD, Director of Chemistry, Superluminal Medicines Inc.
Kevin Halligan, Vice President, Schrödinger
James White, PhD, Director, Collaborative Communications, CDD Vault
 
Deadline for Abstracts: 2025-11-06
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.